PhRMA

JUNE 2, 2023

With Congress discussing policy changes that would lower drug costs for patients and rein in powerful middlemen, insurers and their PBMs are dusting off their old playbook and once again threatening to increase costs for employers if required to do their job and actually provide meaningful coverage to patients. But recent remarks by one executive make clear that the PBM industry has a choice: protect its profits or lower costs for patients.

Insurance 306

Insurance 306

Pharmacy Times

JUNE 2, 2023

Investigators found thinner ventricular walls, disorganized and ruptured myocardial fiber, mild inflammatory infiltration, and mild epicardia or interstitial fibrosis in the hearts of mice infected with COVID-19.

181

181

Drug Topics

JUNE 2, 2023

Yusimry (adalimumab-aqvh) is 1 of 9 FDA-approved adalimumab biosimilars and is a low-concentration, citrate-free product.

FDA 185

FDA 185

Fierce Healthcare

JUNE 2, 2023

Pharma giant Bayer is launching a precision health unit as it ramps up its investment in consumer-facing digital health tools. | Pharma giant Bayer is launching a precision health unit as it ramps up its investment in consumer-facing digital health tools.

145

145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

JUNE 2, 2023

New research suggests that chronotropic incompetence contributes to exercise limitations in Long COVID.

187

187

Pharmacy Times

JUNE 2, 2023

Findings presented at the American Society of Clinical Oncology (ASCO) 2023 meeting show the long-term efficacy and safety profile of larotrectinib (Vitrakvi; Bayer) in solid tumors with NTRK gene fusion.

122

122

Drug Topics

JUNE 2, 2023

Finalizing a definition for postacute sequelae of SARS-CoV-2 infection will lead to high-quality care and treatment for patients suffering from the condition.

98

98

Pharmacy Times

JUNE 2, 2023

Candace Cotto, RN, and Andrew Skinner, MD, discuss barriers to use of FMTs in managing CDI, highlighting clinician and patient education.

123

123

STAT

JUNE 2, 2023

Vince Wescott was ready for top surgery. He had the cash saved up, he’d gotten a letter from his therapist, and he’d sent in the required photos of his chest and torso in preparation for a consultation. When his surgeon’s office called unexpectedly, he picked up, assuming that they were missing paperwork or needed to reschedule.

104

104

Drug Store News

JUNE 2, 2023

The technology provides predictive analytics, quick adjustments for re-ordering and drug forecasting so Publix knows which prescription medications to fast-track to which stores.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JUNE 2, 2023

After weeks of protest from physician organizations and patients, UnitedHealthcare has put a controversial new prior authorization policy for gastroenterology procedures on hold. The policy, which requires physicians and patients to get approval from the insurance giant for nearly all gastroenterology procedures including diagnostic and surveillance colonoscopy or potentially face paying out of pocket, would have gone into effect on June 1.

Insurance 100

Insurance Hospitals 100

Pharmaceutical Technology

JUNE 2, 2023

The European Commission (EC) has approved TG Therapeutics’ Briumvi (ublituximab-xiiy) to treat relapsing forms of multiple sclerosis (RMS) in adult patients. Briumvi is an anti-CD20 monoclonal antibody indicated for RMS adult patients with active disease which is defined by clinical or imaging features. It has been engineered to remove certain sugar molecules generally expressed on the antibody.

FDA 98

FDA 98

STAT

JUNE 2, 2023

I’m standing over an operating table, excising a skin cancer from the forehead of an elderly gentleman while soft piano music echoes off the floor tiles. I’ve performed this procedure thousands of times, and I always enjoy the placid focus and deep satisfaction performing cutaneous surgery brings me. All I’ve done in adulthood has brought me here: cadaver prosections in anatomy labs,  mentorship from dermatologic surgeons , and mastering various  knot-tying techniq

100

100

Hospital Pharmacy Europe

JUNE 2, 2023

Draft NICE guidance has approved rimegepant, a novel oral drug for preventing migraine, which it said could become available to 145,000 NHS patients. Rimegepant is the first drug of its class to come in pill form, with other similar medications administered as injections. The calcitonin gene-related peptide (CGRP) receptor antagonist was also the first of its class to be reviewed by NICE.

Hospitals 98

Hospitals 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JUNE 2, 2023

Several years ago, a local artist asked if she could paint my younger daughter, then a tween, as part of a series of life-size portraits of people she knew. Monica Aissa Martinez really gets under her subjects’ skin — the final product is more medical map than pretty picture, documenting the elements (both scientific and ephemeral) that make a person unique.

Documentation 98

Documentation 98

ISPE

JUNE 2, 2023

ISPE QC/Analytical Community of Practice Established Trudy Patterson Fri, 06/02/2023 - 12:40 iSpeak Blog iSpeak ISPE QC/Analytical Community of Practice Established Tim Postlethwaite Roujian Zhang 2 June 2023 Quality Control (QC) is a vital part of CMC (chemistry, manufacturing, and controls), which ensures the quality and consistency of manufactured drug products.

Method Validation 98

Method Validation 98

STAT

JUNE 2, 2023

Kisqali, a breast cancer pill made by Novartis, reduced the risk of recurrence of the most common type of early breast cancer by 25% in a key trial, researchers said Friday. The findings will likely lead to regulatory approvals and broader use of the medicine, which could represent a financial windfall for Novartis. The company has forecast that the new market for the medicine could reach $3 billion.

97

97

Fierce Healthcare

JUNE 2, 2023

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry players look to expand their businesses and gain a competitive edge. | Missouri's $10 billion health system merger, HCA Healthcare's urgent care pickups and more merger and acquisition news from the month of May.

97

97

STAT

JUNE 2, 2023

WASHINGTON — President Biden plans to tap longtime federal and state health official Mandy Cohen to lead the Centers for Disease Control and Prevention after Rochelle Walensky departs at the end of June , according to three people with knowledge of his plans. If appointed, Cohen would inherit an agency in the midst of assessing its Covid-19 response, including criticisms that it stumbled on test and masking guidance and stoked Americans’ frustration with public health agencies.

94

94

Drug Store News

JUNE 2, 2023

Aloe vera, vitamin E and Arm & Hammer baking soda are infused directly into the wound pad and bandage surface to cover and protect wounds during the healing process.

97

97

STAT

JUNE 2, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. We plan to promenade with our official mascots (yes, we have taken on another, who we will introduce shortly), catch up on our reading, and, if time permits, hold a listening party.

FDA 93

FDA 93

European Pharmaceutical Review

JUNE 2, 2023

A novel refractometry-based process analytical technology (PAT) system used to monitor HEK293T cell cultures during lentiviral vector (LVV) production in real time, was able rapidly identify a relationship between bioreactor pH and culture metabolic activity, a paper has found. Using PAT in the biotechnology and biopharmaceutical industries is a radical vision” Williams et al. stated that to their knowledge, the study represents the first time that pH has been incorporated into a metabolic

95

95

STAT

JUNE 2, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.   That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. However, we are interrupting our usual programming to note that we will return with a featured person next week.

89

89

European Pharmaceutical Review

JUNE 2, 2023

The Centre for Process Innovation (CPI) is set to establish a new UK Intracellular Drug Delivery Centre to develop new lipid nanoparticle (LNP) formulations for RNA medicine delivery, and a framework to advance next-generation nano delivery systems. Under the first-of-its-kind partnership in the UK, CPI will work with the Medicines Discovery Catapult, the University of Strathclyde, the University of Liverpool and Imperial College London using a £10 million, three-year grant funded by Innovate UK

Adverse Reactions 93

Adverse Reactions Vaccines 93

Drug Topics

JUNE 2, 2023

Patients using the treatment reported reduced headache intensity and better quality of life.

98

98

Drug Store News

JUNE 2, 2023

The partnership looks to optimize the beauty brand’s global potential through continued product innovation, talent acquisition and geographic expansion.

94

94

European Pharmaceutical Review

JUNE 2, 2023

Following its announced separation from Novartis in August 2022, Sandoz AG has declared plans to move its headquarters to Basel, Switzerland in mid-2024. With 2022 data by the Swiss federal government establishing that the trend for biotech companies to headquarter in Switzerland is continuing, Sandoz CEO Richard Saynor offered more evidence for this preference: “Basel is a global centre for the life sciences industry, attracting an unrivalled pool of talent and experience” Isma Hachi, D

83

83

Drug Store News

JUNE 2, 2023

Available all summer through Giant Delivers, the local produce boxes will feature an expanded variety of fresh, seasonal produce from local farms.

97

97

Fierce Pharma

JUNE 2, 2023

As Bristol Myers Squibb braces for increasing generic competition this decade, the company is counting on its newer medicines to drive growth. | As Bristol's top-sellers creep toward the patent cliff, new launch Camzyos has picked up a key endorsement in England.

73

73

Drug Store News

JUNE 2, 2023

BJ's Wholesale Club will now have a total of 238 U.S. clubs, expanding the company’s footprint to its 19th state.

105

105

PharmaVoice

JUNE 2, 2023

Healthcare pros share the market drivers they believe are having the biggest impact on the industry.

98

98

Drug Store News

JUNE 2, 2023

CoverGirl and Sally Hansen are working with GLAAD to help flip the script and rewrite the narrative for LGBTQ+ acceptance, the companies said.

89

89

Pharmacy Times

JUNE 2, 2023

Obe-cel is an investigational CD19 CAR T-cell therapy currently in clinical trials for relapsed/refractory B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma.

65

65

Fierce Healthcare

JUNE 2, 2023

Insolvency and a refusal of investors to throw more money at a failing business model forced troubled insurtech Friday Health Plans to shut down, the company confirmed

72

72